Cuba Center Genetic Engineering Biotechnology: But when he pitched the idea of floating a company on the pan-European stock market Euronext with the Cuban state as a shareholder, that was clearly too much, too soon, according to Euro News. I told him in a half serious, half joking mode, that I had a capitalist proposal, Pouletty said of his conversation with Cuban revolutionary leader Fidel Castro eldest son, Fidel Castro Diaz-Balart, a science advisor to the government. A French doctor, venture capitalist and founder of biotech company Abivax, Pouletty is working with Cuba Center for Genetic Engineering and Biotechnology to develop a therapeutic vaccine to treat chronic Hepatitis B that could be on the Asian market in two years and in Europe after that. His response after more than 30 seconds was ‘That indeed very intriguing, but if you want us to reach an agreement quickly, that not the fastest route. Pouletty story offers a peek into the mindset of Cuba Inc. It a few years too soon.’ Instead, Abivax agreed to buy vaccines at a predetermined price and pay royalties to Cuba when the product is on the market.
(news.financializer.com). As
reported in the news.
Tagged under Cuba Center Genetic Engineering Biotechnology, Pouletty topics.